LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $40,000 | +135.3% | 11,697 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -26.1% | 11,697 | 0.0% | 0.00% | – |
| Q2 2020 | $23,000 | 0.0% | 11,697 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -53.1% | 11,697 | 0.0% | 0.00% | – |
| Q4 2019 | $49,000 | -96.4% | 11,697 | -97.4% | 0.00% | -100.0% |
| Q3 2019 | $1,355,000 | -84.0% | 450,000 | -66.7% | 0.00% | -60.0% |
| Q2 2019 | $8,493,000 | +239.4% | 1,350,000 | +200.0% | 0.01% | +25.0% |
| Q1 2019 | $2,502,000 | +45.5% | 450,000 | +330.4% | 0.00% | +33.3% |
| Q2 2017 | $1,720,000 | +75.7% | 104,566 | +53.2% | 0.00% | +50.0% |
| Q1 2017 | $979,000 | +3.5% | 68,266 | -0.2% | 0.00% | 0.0% |
| Q4 2016 | $946,000 | -6.3% | 68,431 | +22.4% | 0.00% | 0.0% |
| Q3 2016 | $1,010,000 | – | 55,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |